https://journals.bilpubgroup.com/index.php/jams/issue/feed 2022-11-15T08:49:37+08:00 Managing Editor editoria-jams@bilpublishing.com Open Journal Systems <table><tbody><tr><td align="center" valign="top" width="200" height="202"><p><a href="/index.php/jams" target="_black"><img style="width: 200px; margin-right: 20px; -moz-border-radius: 5px; border-radius: 5px; box-shadow: 5px 5px 5px #ccc;" src="/public/site/images/shuangyu/yx.jpg" alt="" /></a></p><p>ISSN: 2591-7617(Online)</p><p> 2591-7609(Print)</p><p>Email:contact@bilpublishing.com</p><p><a href="/index.php/jams/about/submissions#onlineSubmissions" target="_black"><button style="background-color: #2c58a6; color: #fff; border-radius: 5px; height: 35px; width: 150px;">Online Submissions</button></a></p></td><td style="text-align: justify;" align="right" valign="top"><p><em><strong>Journal of Advances in Medicine Science</strong></em> is an covering all aspects of Medical Science, papers include fields of the basic and clinical medicine science research.<br /> The mission of the Journal is to foster and promote multidisciplinary studies, especially the practice, policy and theory of Medicine. Its purpose is to take the lead in timely publication in the areas of Medicine. Making such information available will ultimately promote the publish and exchange views of new achievements in medicine.<br /> <span>The journal publishes regular papers, short communications, and review articles with a view of providing a focus for new information in all respects of Medical Science.</span><br /> <span>Regular papers should present new experimental studies that constitute a significant contribution to existing knowledge. Theoretical papers which deal with new ideas and concepts based on earlier findings will also be welcome.</span><br /> <span>Short communications should present important new findings in a brief form.</span><br /> <span>Review articles should cover the most important current topics or present interpretative and critical accounts. They should not be simple compilations on subjects of general interest. Review articles are published only by invitation of the Editor-in-Chief. Authors intending to prepare a review should first contact the Editors.</span></p><p><span>The scope of the papers in this journal includes, but is not limited to:</span></p><ul><li>Medical theory research</li><li>Clinical medicine research</li><li>Medical practice</li><li>Health care medicine</li><li>Preventive medicine</li><li>Nursing medicine</li><li>Medicine and medicinal chemistry</li><li>Hospital management</li><li>Integrated traditional Chinese and Western medicine treatment</li><li>Health policy</li><li>Continuing medical education</li><li>Health management</li></ul></td></tr></tbody></table> https://journals.bilpubgroup.com/index.php/jams/article/view/4441 2022-11-15T08:49:37+08:00 Yiqun Wang s2073600@ed.ac.uk

<p>The advent of antimicrobial drugs has made a huge contribution to human society, but their commodity nature has given rise to behaviors such as abuse and overuse, leading to the emergence of resistance to antimicrobial drugs and other hazards. Nowadays, the structure of interests formed by various stakeholders in the market circulation of antimicrobial agents has become unbalanced, and government intervention as a breakthrough still faces many challenges. This paper discusses the AMR challenges of government intervention under the interest structure in the context of case studies in the Global North and the Global South areas from the point of view of human health in terms of stagnant R &amp; D processes for novel antimicrobial drugs, a profit-oriented neoliberal atmosphere that mismatches production trends of antimicrobial drugs with market demand, the prevalence of private institutions lacking effective regulation, incomplete government interventions, and the difficulty of pursuing the WHO strategic plan on antimicrobial resistance, etc.</p>

2022-11-15T00:00:00+08:00 Copyright © 2022 Yiqun Wang https://journals.bilpubgroup.com/index.php/jams/article/view/4671 2022-11-15T08:49:37+08:00 Yanqin Ruan 1379770939@qq.com Haofe Li 15559795569@163.com Chang Liu 13223065642@163.com

<p class="p" align="justify">The incidence of aortic dissection (AD) is estimated to be 1 in 100,000 per year. The onset and progression of AD are rapid. Failure to receive appropriate treatment might lead to death in a short time. Even following active treatment, patients might develop low cardiac output syndrome, severe infection, and hemorrhage, which lead to death. Interventional therapy is a surgical method that has been widely used in Stanford type B AD recently. It is characterized by minimal invasiveness, low incidence of postoperative complications, and low cost. This article will review the interventional treatments for AD and will guide the selection of treatment options.</p>

2022-11-15T00:00:00+08:00 Copyright © 2022 Chang Liu https://journals.bilpubgroup.com/index.php/jams/article/view/5231 2022-11-15T08:49:37+08:00 Shan Su 246004606@qq.com

<p>Cancer Rehabilitation is a new discipline, a combination of tumor medication, immunology, psychology, nutritional science and exercise physiology etc.. The core of cancer rehabilitation is the therapy of natural immunology, which aims at activating T-cells, and restoring the bone marrow function impaired during chemo-radiation therapy. Cancer rehabilitation seeks to achieve the gradual recovery of the immune system, which in turn hinders recurrence and metastasis. In addition, with the help of psychological consultation, nutritional and physical exercise guidance, cancer patients may have a better chance at managing the risk of recurrence and metastasis, extending life expectancy with an improved quality of life. </p>

2022-11-15T00:00:00+08:00 Copyright © 2022 Shan Su